Collections

Business on the Front Lines

News and perspectives from corporations working to directly impact the COVID-19 public health crisis. Content from this collection may include updates from medical supply or pharmaceutical companies, businesses that have pivoted their production to support the medical response to COVID-19 or hospitals that are navigating many secondary impacts of the pandemic (both economic and human).

Covid-19 Vaccine Study Results Could Come Late October, Moderna CEO Says - WSJ

Covid-19 Vaccine Study Results Could Come Late October, Moderna CEO Says

By: Peter Loftus
Source: The Wall Street Journal
Date of Publication: September 17th, 2020
Company also released the guidelines for the shot’s final-stage trial.
Pfizer says late-stage coronavirus vaccine study shows moderate side effects

Pfizer says late-stage coronavirus vaccine study shows moderate side effects

By: Manas Mishra
Source: Reuters
Date of Publication: September 15th, 2020
Pfizer Inc said on Tuesday participants were showing mild-to-moderate side effects when given either the company’s experimental coronavirus vaccine or a placebo in an ongoing late-stage study.
U.S. weekly jobless claims flattening; labor market recovery showing signs of fatigue

U.S. weekly jobless claims flattening; labor market recovery showing signs of fatigue

By: Lucia Mutikani
Source: Reuters
Date of Publication: September 10th, 2020
The number of Americans filing new claims for unemployment benefits hovered at high levels last week, suggesting the labor market recovery from the COVID-19 pandemic was stalling.
Americans splurged over Labor Day weekend. That's the good news

Americans splurged over Labor Day weekend. That's the good news

By: Howard Schneider
Source: Reuters
Date of Publication: September 10th, 2020
People flocked to stores - and back to restaurants - over Labor Day weekend in the United States, setting post-pandemic highs for retail foot traffic and seated dining but also posing a puzzle.
Boston Dynamic robot dogs are being used to monitor COVID-19 patients

If you’re in the hospital with COVID-19, this robot dog might come take your vital signs

By: Adele Peters
Source: Fast Company
Date of Publication: September 3rd, 2020
Dr. Spot will see you now. A study found the robots were good at gathering information from patients—and the patients like them too.
Vaccine makers pledge safety will be foremost - The Washington Post

Vaccine CEOs issue safety pledge amid Trump’s quest for pre-election approval

By: Christopher Rowland
Source: The Washington Post
Date of Publication: September 8th, 2020
Nine chief executives issued an extraordinary joint statement Tuesday seeking to bolster faith in coronavirus vaccine.
Covid-19 Vaccine Race Turns Deep Freezers Into a Hot Commodity - WSJ

Covid-19 Vaccine Race Turns Deep Freezers Into a Hot Commodity

By: Jared S. Hopkins
Source: The Wall Street Journal
Date of Publication: September 4th, 2020
Drug, logistics and public-health officials assemble a cold-storage supply chain as experimental vaccines approach the end of late-stage testing.
US stockpiling 3 different types of coronavirus vaccines through 'Operation Warp Speed' _ Fox Business

US stockpiling 3 different types of coronavirus vaccines through 'Operation Warp Speed'

By: Megan Henney
Source: Fox Business
Date of Publication: September 1st, 2020
Trump administration's Operation Warp Speed has doses -- none of which have been approved or authorized for use -- from 3 companies.
U.S. scraps Philips ventilator order in 2020 earnings blow

U.S. scraps Philips ventilator order in 2020 earnings blow

Source: Reuters
Date of Publication: August 31st, 2020
Philips (PHG.AS) said the U.S. Department of Health had cancelled most of an order for 43,000 ventilators, leading the Dutch medical equipment maker to cut its 2020 earnings outlook.
GSK, partner Vir join race to find COVID-19 antibody treatment

GSK, partner Vir join race to find COVID-19 antibody treatment

Source: Reuters
Date of Publication: August 31st, 2020
GlaxoSmithKline and partner Vir Biotechnology have started testing their experimental antibody on early-stage COVID-19 patients, entering the race to find a winner in a promising class of antiviral drugs to combat the pandemic.

Browse Collections

  • The Changing Nature of Work COVID-19

    The Changing Nature of Work

    From virtual offices to essential workers, explore how companies are adapting to changes in the way we work.
    Read More
  • Business on the Front Lines COVID-19

    Business on the Front Lines

    News and perspectives from corporations rising to the challenge of the COVID-19 public health crisis.
    Read More
  • Leading in a Crisis COVID-19.

    Leading in a Crisis

    Uncertainty can be disorienting and disruptive. Learn from business leaders about what it’s like to navigate their organizations and people through a global pandemic.
    Read More
  • Service and Community COVID-19

    Service and Community

    We’re in this together. Discover ways corporations are serving their communities and pivoting to become essential services.
    Read More